This inventor holds 1 USPTO granted patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Carolyn Stenbak: Innovator in Reverse Transcriptase Technology
Introduction
Carolyn Stenbak is a notable inventor based in Gif-sur-Yvette, France. She has made significant contributions to the field of biotechnology, particularly in the development of reverse transcriptase technology. Her work has implications for various applications in molecular biology and genetic research.
Latest Patents
Stenbak holds a patent for a highly processive reverse transcriptase derived from foamy virus. This invention, titled "Foamy virus mutant reverse transcriptase," relates to a reverse transcriptase that exhibits DNA polymerase activity while having substantially reduced protease activity. The invention includes an isolated reverse transcriptase from foamy virus, which comprises a substantially inactivated protease. Additionally, it encompasses vectors containing the gene and hosts transformed with the vector. The patent also outlines methods for producing reverse transcriptase with the desired properties and kits for preparing cDNA from RNA.
Career Highlights
Stenbak is affiliated with the Fred Hutchinson Cancer Center, where she continues her research and development efforts. Her work at this prestigious institution has allowed her to collaborate with leading scientists in the field.
Collaborations
Some of her notable coworkers include Stephen H. Hughes and Patrick Clark, who have contributed to her research endeavors.
Conclusion
Carolyn Stenbak's innovative work in reverse transcriptase technology exemplifies her commitment to advancing biotechnology. Her contributions are vital for ongoing research and applications in molecular biology.